Delivery Order SPE2DB20D1004-SPE2DB25FNKYV
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,684.93 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPin 2-pack auto-injectors (0.5mg/0.1ml) with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The GVOKE HypoPin is a glucagon emergency injection system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a delivery order valued at $3,345.20 to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-competitive delivery order is priced on a firm fixed price basis and will be performed at the contractor's location in Conshohocken, Pennsylvania. GVOKE is a glucagon injection used for emergency treatment of severe hypoglycemia in diabetic patients, representing...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.00 to AmerisourceBergen Drug Corp for GVOKE HypoKit 2-pack auto-injectors (1 mg/0.2 mL) on June 4, 2025, with completion scheduled for June 5, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The GVOKE HypoKit is a critical emergency medication delivery system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a $2,540.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoOpen 2-pack auto-injectors (1 mg/0.2 mL) on June 2, 2025, with completion targeted for June 3, 2025. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $17.5K to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) on July 14, 2025, with completion expected by July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Corporate Office location in Conshohocken, Pennsylvania. The product is an emergency glucagon auto-injector used for treating severe hypoglycemia in patients with diabetes,...